← Go Back
Pharma, Other Countries

Policy on the Handling of Pharmaceutical Patents in Relation to the Approval Review under the Pharmaceuticals and Medical Devices Act and the National Health Insurance Price Listing of Medical-use Generic Drugs and Biosimilars - Japan (2025)